{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:13:37Z","timestamp":1788182017849,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,3]],"date-time":"2027-06-03T00:00:00Z","timestamp":1811980800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013289","name":"ERA-LEARN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006544","name":"State of Israel Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000223","name":"Muscular Dystrophy Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymthe.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:08:50Z","timestamp":1772852930000},"page":"3224-3230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3011-3175","authenticated-orcid":false,"given":"Iddo","family":"Magen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Marlene","family":"Kaneb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masnata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Pulimood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Emde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Genge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Hornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.002_bib1","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1056\/NEJMc1710379","article-title":"Amyotrophic Lateral Sclerosis","volume":"377","author":"Tsai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.002_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.002_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene discovery in amyotrophic lateral sclerosis: implications for clinical management","volume":"13","author":"Al-Chalabi","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1038\/emboj.2012.319","article-title":"FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment: FUS participates in microRNA biogenesis","volume":"31","author":"Morlando","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1073\/pnas.1112427109","article-title":"TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes","volume":"109","author":"Kawahara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U A."},{"key":"10.1016\/j.ymthe.2026.03.002_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5264","article-title":"Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology","volume":"11","author":"Reichenstein","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.002_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-6606-6-26","article-title":"Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels","volume":"6","author":"Campos-Melo","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ymthe.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2015.12.008","article-title":"Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms","volume":"71","author":"Figueroa-Romero","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.15252\/embj.201490493","article-title":"Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS","volume":"34","author":"Emde","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.002_bib11","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"miRNA malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U A."},{"key":"10.1016\/j.ymthe.2026.03.002_bib12","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U A."},{"key":"10.1016\/j.ymthe.2026.03.002_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molcel.2020.02.020","article-title":"Ago2-Dependent Processing Allows miR-451 to Evade the Global MicroRNA Turnover Elicited during Erythropoiesis","volume":"78","author":"Kretov","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1073\/pnas.1014720108","article-title":"Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing","volume":"108","author":"Melo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U A."},{"key":"10.1016\/j.ymthe.2026.03.002_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.1481","article-title":"A small molecule enhances RNA interference and promotes microRNA processing","volume":"26","author":"Shan","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.002_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fpsyt.2014.00006","article-title":"Enoxacin Elevates MicroRNA Levels in Rat Frontal Cortex and Prevents Learned Helplessness","volume":"5","author":"Smalheiser","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.03.002_bib17","article-title":"IsomiR utility in amyotrophic lateral sclerosis prognostication","volume":"7","author":"Cohen","year":"2026","journal-title":"Med. N. Y."},{"key":"10.1016\/j.ymthe.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2026.03.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105323","article-title":"Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis","volume":"108","author":"Benatar","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","article-title":"MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice","volume":"326","author":"Williams","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.002_bib21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.33594\/000000099","article-title":"The microRNA miR-375-3p and the Tumor Suppressor NDRG2 are Involved in Sporadic Amyotrophic Lateral Sclerosis","volume":"52","author":"Rohm","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jnc.14229","article-title":"Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9","volume":"145","author":"Zhou","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mus.26106","article-title":"Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis","volume":"58","author":"Raheja","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0022-3565(24)36944-7","article-title":"Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro","volume":"282","author":"Sanderink","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2026.03.002_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cpdd.1168","article-title":"Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film","volume":"12","author":"Wymer","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ymthe.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1128\/AAC.43.6.1511","article-title":"Pharmacokinetic-Pharmacodynamic Contributions to the Convulsant Activity of Fluoroquinolones in Rats","volume":"43","author":"Delon","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymthe.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/48.6.813","article-title":"A pharmacokinetic\/pharmacodynamic approach to show that not all fluoroquinolones exhibit similar sensitivity toward the proconvulsant effect of biphenyl acetic acid in rats","volume":"48","author":"Marchand","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ymthe.2026.03.002_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/14.suppl_C.57","article-title":"Diffusion of enoxacin into the cerebrospinal fluid in dogs with healthy meninges and with experimental meningitis","volume":"14","author":"Tho","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ymthe.2026.03.002_bib29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1248\/bpb.20.931","article-title":"Effect of Acute Renal Failure on Neurotoxicity of Enoxacin in Rats","volume":"20","author":"Kawakami","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ymthe.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fnins.2017.00731","article-title":"Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity","volume":"11","author":"Waller","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymthe.2026.03.002_bib31","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.03.002_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp-2020-324647","article-title":"Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72 -associated frontotemporal dementia and amyotrophic lateral sclerosis","volume":"92","author":"Kmetzsch","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2026.03.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157998","article-title":"Circulating MicroRNAs: Association with Lung Function in Asthma","volume":"11","author":"Kho","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ymthe.2026.03.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111723","article-title":"Associations of plasma miRNAs with waist circumference and insulin resistance among women with polycystic ovary syndrome \u2013 Pilot study","volume":"554","author":"Wander","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ymthe.2026.03.002_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2017.03.041","article-title":"Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome","volume":"261","author":"Wang","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymthe.2026.03.002_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:15:11Z","timestamp":1788178511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1525001626001875"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.002","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}